Castleview Partners’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.38M | Buy |
3,558
+390
| +12% | +$152K | 0.89% | 25 |
|
|
2025
Q1 | $1.38M | Buy |
3,168
+842
| +36% | +$366K | 0.93% | 23 |
|
|
2024
Q4 | $851K | Buy |
+2,326
| New | +$851K | 0.46% | 51 |
|
|
2024
Q3 | – | Sell |
-2
| Closed | -$1.08K | – | 648 |
|
|
2024
Q2 | $1.08K | Hold |
2
| – | – | ﹤0.01% | 803 |
|
|
2024
Q1 | $1.04K | Buy |
+2
| New | +$1.04K | ﹤0.01% | 794 |
|
|
2023
Q2 | – | Sell |
-35
| Closed | -$16.1K | – | 696 |
|
|
2023
Q1 | $16.1K | Buy |
+35
| New | +$16.1K | 0.01% | 367 |
|
|
2022
Q4 | – | Sell |
-70
| Closed | -$32K | – | 671 |
|
|
2022
Q3 | $32K | Buy |
+70
| New | +$32K | 0.03% | 294 |
|
|
2022
Q2 | – | Sell |
-70
| Closed | -$34K | – | 773 |
|
|
2022
Q1 | $34K | Sell |
70
-16,617
| -100% | -$8.07M | 0.02% | 387 |
|
|
2021
Q4 | $36 | Buy |
+16,687
| New | +$36 | ﹤0.01% | 909 |
|
|
2021
Q2 | $30K | Buy |
+78
| New | +$30K | 0.01% | 494 |
|